uracil has been researched along with Compensatory Hyperinsulinemia in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These results provide a strong argument for using alogliptin in combination with pioglitazone." | 1.35 | The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. ( Asakawa, T; Kataoka, O; Moritoh, Y; Odaka, H; Takeuchi, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moritoh, Y | 1 |
| Takeuchi, K | 1 |
| Asakawa, T | 1 |
| Kataoka, O | 1 |
| Odaka, H | 1 |
1 other study available for uracil and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice.
Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Eating; | 2009 |